Centering on the current state and future prospects of the pipeline, the positioning of the drug discovery support business and drug discovery business, and the status of key pipelines in clinical development; also describes market size, assumed share, and development costs, with an outline of 2026 plans and mid- to long-term plans.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4572","jir_company_name":"\u30ab\u30eb\u30ca\u30d0\u30a4\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u30ba\u682a\u5f0f\u4f1a\u793e","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4572-20260806-02.pdf","jir_short_summary":"Centering on the current state and future prospects of the pipeline, the positioning of the drug discovery support business and drug discovery business, and the status of key pipelines in clinical development; also describes market size, assumed share, and development costs, with an outline of 2026 plans and mid- to long-term plans.","jir_summary":"### Section Heading\nBusiness overview: Positioning drug discovery and drug discovery support as core,\u6574\u7406 the development status of the pipeline, market opportunities, anticipated market size and competitive landscape. Illustrates the status of clinical trials, phase progression timelines,\u4e0a\u5e02 strategy, and path to monetization.\n\n### Section 2 Heading\nCurrent pipeline status and outlook: Explain current clinical trial status, progress in Phases 1\/2\/3, future plans and funding policies, and framework for partnerships and licensing strategies. Allocation of R&D expenses and funding strategy is unknown.","jir_financial_highlights":"Sales: Unknown (Unknown)\nOperating profit: Unknown (Unknown)\nNet income: Unknown (Unknown)","jir_category":"","jir_hashtags":"#CarlBioSciencesUnspecified #InHousePipeline #DrugDiscoverySupportBusiness #DrugDiscoveryBusiness","jir_key_figures":"Key figure 1: Unknown (no specific values for revenue and costs disclosed)\nKey figure 2: Unknown (no specific figures for clinical trial phases or market size disclosed)\nKey figure 3: Unknown (no quantitative values for\u4e0a\u5e02 timing and use of funds disclosed)","jir_meta_title":"\u3010Carl BioSciences\u3011Drug Discovery Pipeline and Business Strategy | Unknown","jir_meta_description":"Overview of Carl BioSciences' drug discovery pipeline and business strategy. Summarizes current clinical development,\u4e0a\u5e02 strategy, and investor-relevant points in the IR material.","jir_og_title":"Carl BioSciences | Drug Discovery Pipeline and Strategy","jir_og_description":"Summary of the company's pipeline status and future prospects, clinical development progress, and\u4e0a\u5e02 plan overview centered on drug discovery and related services.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":59427,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-98108","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n